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Abstract 
A 78-year old man was diagnosed with a left
bleeding renal cyst from CT scan results. Serial
CT scans revealed the left kidney mass to be
increasing in size and a new lesion in the liver.
Renal cell carcinoma with liver metastasis was
diagnosed  and  a  radical  nephrectomy  per-
formed. The initial pathological diagnosis was
a  benign  chronic  hematoma.  However,  the
liver  mass  increased  in  size  and  multiplied,
while  another  mass  emerged  in  the  twelfth
thoracic vertebra with spinal paralysis and was
immediately  removed.  Pathological  findings
for that specimen showed malignancy of stro-
mal cell origin but low atypia. The renal speci-
men was re-evaluated using whole cross-sec-
tion analysis and immunohistochemistry, and
diagnosed as a primary renal angiosarcoma.
Recombinant interleukin-2 therapy was start-
ed immediately; however, the patient died of
metastatic disease 13 months after the initial
operation. Although contrast imaging depicted
the primary lesion as a non-specific hematoma
with little focal pooling, and low-grade cytolog-
ical  atypia  was  shown  pathologically,  the
angiosarcoma was extremely aggressive.
Introduction
Angiosarcomas comprise only two percent of
all  soft  tissue  sarcomas.
1 The  large  majority
originate from the skin of the scalp and face,
while those with a visceral origin including the
kidneys are extremely rare.
2 Recently we treat-
ed a case of primary renal angiosarcoma, in
which a prompt and exact diagnosis was diffi-
cult to obtain. We report here a brief review of
the literature and the clinical course of this
malignancy.
Case Report
The patient was a 78-year old Japanese man,
who was treated previously for a peptic ulcer,
an  abdominal  aortic  aneurysm,  and  angina
pectoris. He had been employed until the age
of 60 years old in the production of plastic auto
parts, such as those made from polyethylene
and  acrylonitrile-butadiene-styrene  copo-
lymer.
In May 2006, the patient noticed a bruise on
his back after falling and become aware of per-
sistent pain in his left flank. He consulted a
family doctor, who diagnosed the condition as
a hemorrhage from a left renal cyst and pre-
scribed conservative treatment. However, the
symptoms  remained  and  the  patient  was
referred to our hospital three months later.
Routine blood tests showed the presence of
anemia  and  an  IAP  value  that  increased  to
1060, while other parameters were within the
normal  range  and  a  urine  test  showed  no
abnormal  findings  including  hematuria.  An
abdominal CT scan demonstrated a distinctly
bordered mass located on the upper pole of the
left kidney that measured approximately 14 cm
in  maximum  diameter.  The  images  also
showed that the distribution of contrast mate-
rial  was  limited  to  the  margin  of  the  mass
without  focal  pooling,  which  suggested  that
the  central  part  was  hemorrhagic  or  necro-
tized,  while  the  periphery  had  no  obvious
tumor formation (Figure 1). Additionally, CT
scanning depicted a newly developed low den-
sity area with poor contrast in the sixth seg-
ment  of  the  liver  (Figure  1).  Therefore,  we
considered that the lesions located in the left
kidney and liver corresponded, respectively, to
primary renal and metastatic hepatic lesions of
renal cell carcinoma. We performed a radical
nephrectomy  in  August  2006  in  order  to
achieve tumor cytoreduction. The excised kid-
ney was 960 g in weight, while the tumorous
lesion was approximately 18x11x7 cm in size,
and composed of a non-specific hematoma and
surrounding fibrous capsule (Figure 2). The
initial  pathological  diagnosis  was  a  chronic
hematoma with no evidence of malignancy. 
Two months after the operation, follow-up
CT  scans  showed  the  hepatic  lesion  to  be
increasing in size and multiplying; however,
we  were  not  able  to  perform  a  liver  biopsy
because of the high risk of bleeding or rupture.
Four months after the operation, spinal paraly-
sis  developed  suddenly,  and  MR  imaging
revealed a new tumor that had destroyed the
twelfth thoracic vertebra and compressed the
adjacent spinal cord. The tumor was removed
immediately  by  orthopedic  surgeons.
According to the pathological report, the tumor
in the thoracic vertebra was composed of spin-
dle  cells  with  mildly  atypical  nuclei  and  a
sheet-like appearance, and which were prolif-
erating and infiltrating the surrounding area.
Following the second surgery, cross-sections of
the total kidney specimen were prepared and
subjected to re-evaluation, which demonstrat-
ed  spindle-shaped  tumor  cells,  the  same  as
those seen in the thoracic vertebra (Figure 3). 
Immunohistochemistry  findings  showed
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Figure 1. Abdominal CT scan findings obtained before the initial operation. An approx-
imately 14 cm-sized mass with a distinct border was found located on the upper pole of
the left kidney (A). The distribution of contrast material was limited to its margin with-
out pooling. A new lesion that later developed in the sixth segment of the liver was shown
as a low density area with poor enhancement (B). 
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that the neoplastic cells were not positive for
cytokeratin,  a  marker  of  epithelial  cells,  but
rather for vimentin, a marker of mesenchymal
cells. The neoplastic cells were positive also for
factor VIII-related antigen, CD31, and CD34,
which are markers of endothelial cells, and for
VEGF and its receptor, Flk-1. These immuno-
histochemical findings supported a final diag-
nosis of angiosarcoma. Immediately after the
final  diagnosis,  recombinant  interleukin-2
monotherapy (35~70 C x 10
4 IU three times a
week for a total dose of 22x10
6 IU) was started
for  the  liver  metastases  in  February  2007.
However,  the  patient  died  of  metastatic  dis-
ease 13 months after the initial operation.
Discussion
Angiosarcomas comprise only two percent of
all  soft  tissue  sarcomas,
1 while  those  deeply
located including a primary renal angiosarco-
ma  are  extremely  rare.
2 To  the  best  of  our
knowledge, 25 cases of primary renal angiosar-
coma have been reported in the English litera-
ture until the end of 2007, and the outcome for
nearly  all  of  the  affected  patients  has  been
extremely poor.
3-6The main cause for poor prog-
nosis is the difficulty of prompt and accurate
diagnosis, especially for angiosarcomas in deep
organs such as the kidneys. In the present case,
because the actual tumor size was extremely
small, CT scanning failed to exhibit the exact
tumor shape with abnormal contrast pooling,
while a pathological examination also failed to
provide an accurate diagnosis without cross-
sections from the entire specimen. In addition,
a  precise  pathological  diagnosis  required
immunohistochemistry analysis,
7 as the tumor
cells lacked some particular features, such as a
vascular  architecture.  In  patients  with  an
angiosarcoma of the kidney, a prompt and exact
diagnosis  is  not  easy  to  obtain  in  the  early
stage, because clinical symptoms generally do
not develop at that point, and the disease often
shows rapid growth and metastasis. Therefore,
effective systemic treatments as standard ther-
apies are needed, although they have yet to be
established.  In  recent  years,  new  treatments
such  as  immunotherapy,  including  recombi-
nant interleukin-2 (rIl-2) administration,
8 and
molecular  targeting  therapies  using  beva-
cizumab
9 and  sorafenib
10 have  been  utilized
increasingly. However, the long-term and large-
scale effectiveness of these therapies remains
to be assessed. We applied rIl-2 therapy to the
liver metastasis in our patient via intravenous
administration. The patient showed good toler-
ance  for  the  drug;  however,  the  metastatic
lesions  did  not  show  a  response,  possibly
because the drug was given as monotherapy
and in a low dose, and also because the disease
was well advanced at the time of the initial
administration. 
In  conclusion,  the  present  case  confirmed
the aggressive biological behavior of a primary
angiosarcoma of the kidney, regardless of its
relatively gentle features in imaging and patho-
logical  examinations.  It  is  important  to  be
aware of the possibility of angiosarcoma as well
as  more  well-known  malignancies  such  as
renal cell carcinoma when treating a patient
with an unusual hematoma of the kidney.
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Figure 2. Macroscopic appearance of affected kidney. The mass was located on the upper
pole  of  the  left  kidney.  The  majority  of  the  lesion  was  occupied  by  a  non-specific
hematoma and its periphery was composed of fibrous tissue. No neoplastic lesions were
observed in macroscopic observations. 
Figure 3. Microscopic findings of the primary renal lesion. Most areas of the specimens
were occupied by the non-specific hematoma, whereas the tumor was located in the
periphery of the hematoma (A). Spindle-shaped tumor cells with low-grade atypia had
proliferated and invaded the adjacent parenchyma, which exhibited a sheet-like forma-
tion with no vascular architecture (B). The tumor cells were positive for CD31 (C), and
VEGF (D).
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